Cancer

America’s biopharma research companies are testing 981 medicines and vaccines to fight the many types of cancer affecting millions of patients worldwide. All of the medicines are either in clinical trials or awaiting review by the Food and Drug Administration (FDA).

 

“Despite amazing strides in the ongoing battle against cancer, the many forms of this disease remain a major public health challenge for patients, their families, healthcare providers and economies in the United States and throughout the world,” said PhRMA President and CEO John J. Castellani. “The ceaseless efforts of biopharmaceutical researchers in America have brought new and improved treatment options to patients, creating hope that didn’t exist before. This report represents the next chapter of hope; it’s a story of amazing science, individual perseverance and a sector-wide commitment to patients.”